Resolve Therapeutics Lands $1,083,334 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=62ba0bdd-bfdb-4ba8-aef8-aadfacaa7af6&Preview=1
Date
4/26/2012
Company Name
Resolve Therapeutics
Mailing Address
5400 Carillon Point Kirkland, WA 98033
Company Description
Resolve Therapeutics is a privately held biotechnology company based in Seattle that is dedicated to helping patients with lupus through the development of RSLV-125, its novel targeted biologic therapy.
Website
http://www.resolvebio.com
Transaction Type
Debt
Transaction Amount
$1,083,334
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed